Public Employees Retirement System of Ohio Buys New Position in Cellebrite DI Ltd. (NASDAQ:CLBT)

Public Employees Retirement System of Ohio purchased a new stake in Cellebrite DI Ltd. (NASDAQ:CLBT) in the third quarter, Holdings Channel.com reports. The fund purchased 293,115 shares of the company’s stock, valued at approximately $4,936,000.

Several other large investors have also bought and sold shares of CLBT. Telemark Asset Management LLC purchased a new stake in shares of Cellebrite DI in the third quarter valued at about $6,736,000. Two Sigma Advisers LP grew its position in Cellebrite DI by 9.8% in the 3rd quarter. Two Sigma Advisers LP now owns 1,341,100 shares of the company’s stock worth $22,584,000 after purchasing an additional 120,000 shares in the last quarter. Scalar Gauge Management LLC increased its stake in Cellebrite DI by 15.2% in the 2nd quarter. Scalar Gauge Management LLC now owns 453,554 shares of the company’s stock valued at $5,420,000 after buying an additional 60,000 shares during the last quarter. Connors Investor Services Inc. bought a new position in shares of Cellebrite DI during the 2nd quarter worth approximately $1,803,000. Finally, Principal Financial Group Inc. purchased a new position in shares of Cellebrite DI in the 3rd quarter worth approximately $23,402,000. 45.88% of the stock is currently owned by institutional investors.

Cellebrite DI Stock Down 0.8 %

NASDAQ CLBT opened at $19.88 on Friday. The company has a fifty day moving average of $18.93 and a 200-day moving average of $15.75. Cellebrite DI Ltd. has a 52-week low of $7.91 and a 52-week high of $21.72.

Cellebrite DI (NASDAQ:CLBT) last issued its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, beating analysts’ consensus estimates of $0.09 by $0.05. The business had revenue of $106.90 million for the quarter, compared to analysts’ expectations of $102.06 million. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business’s quarterly revenue was up 27.0% on a year-over-year basis. During the same period last year, the business earned $0.09 earnings per share. On average, analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Analysts Set New Price Targets

A number of analysts recently commented on the company. TD Cowen increased their price target on Cellebrite DI from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, September 23rd. Craig Hallum raised their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Needham & Company LLC increased their price target on shares of Cellebrite DI from $17.00 to $21.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Cellebrite DI from $21.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of “Buy” and an average target price of $20.29.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.